Bluesphere Advisors LLC Has $1.45 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bluesphere Advisors LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,754 shares of the healthcare conglomerate’s stock after acquiring an additional 140 shares during the period. UnitedHealth Group makes up approximately 0.9% of Bluesphere Advisors LLC’s investment portfolio, making the stock its 21st largest holding. Bluesphere Advisors LLC’s holdings in UnitedHealth Group were worth $1,450,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of UNH. Verdence Capital Advisors LLC raised its stake in UnitedHealth Group by 2.1% in the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after buying an additional 342 shares during the period. Ascension Capital Advisors Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at about $216,000. Bellecapital International Ltd. lifted its position in UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares during the last quarter. Great Valley Advisor Group Inc. grew its position in shares of UnitedHealth Group by 5.8% in the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after purchasing an additional 1,884 shares during the last quarter. Finally, Rise Advisors LLC increased its position in UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after buying an additional 163 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on UNH shares. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Trading Down 1.0 %

UNH traded down $4.98 during trading on Monday, reaching $490.37. 835,342 shares of the stock traded hands, compared to its average volume of 4,462,741. The stock’s 50-day moving average is $485.84 and its 200 day moving average is $514.07. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $451.18 billion, a PE ratio of 30.02, a P/E/G ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the firm earned $6.26 earnings per share. The company’s revenue was up 8.6% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.